nVerses Capital’s Arcosa ACA Stock Holding History

nVerses Capital’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-300	Closed	-$25K	–	960
2024 Q2	$25K	Buy	+300	New	+$25K	0.01%	742

Other funds holding ACA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

nVerses Capital's ACA Position: Q3 2024 in Review

nVerses Capital sold out of Arcosa (ACA) in Q3 2024, closing a stake of 300 shares — an estimated $25K sold.

nVerses Capital first reported a position in ACA in Q2 2024 and held it in 1 quarter. The position peaked at $25K in Q2 2024. 324 funds tracked by Wall St. Rank hold ACA as of Q3 2024.

nVerses Capital reported no remaining Arcosa position as of Q3 2024 after selling out during the quarter.
nVerses Capital sold 300 Arcosa shares in Q3 2024, an estimated $25K.
nVerses Capital first reported a position in Arcosa in Q2 2024 and held it in 1 quarter.
nVerses Capital's Arcosa position peaked at $25K in Q2 2024.
324 funds tracked by Wall St. Rank held Arcosa as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.